Jun Li

Head Of Oncology GemPharmatech

Seminars

Wednesday 2nd December 2026
Precision Preclinical Model Selection for Modern Cancer Immunotherapy
1:50 pm
  • Why conventional murine models fail to recapitulate human immune–tumour interactions
  • Matching therapeutic modalities to purpose-built humanized immune architectures
  • Leveraging translational services to de-risking clinical translation and Go/No-Go decisions
Wednesday 2nd December 2026
Insights Exchange – How Should Teams Select the Right Model Under Real World Constraints?
2:40 pm
  • What characteristics consistently appear in models that successfully predict patient outcomes?
  • Where do models most commonly fail despite encouraging preclinical data?
  • Which translational endpoints should teams prioritise when evaluating model performance
  • Audience Q&A
Jun Li